Kyowa Kirin International NewCo Sweden AB

Lee Hyun-hee

Manager

Hajime Kobayashi

Outside Audit & Supervisory Board Member (Full-time)

Greg Palko

Vice President, North America, Oncology Franchise Head

Rumiko Nakata

Outside Director of the Board

Steve Schaefer

President, North America

Julie Dehaene-Puype

President, Kyowa Kirin International plc

Yoshiko Mori

Managing Executive Officer and Chief Compliance Officer (CCO)

Takeshi Matsushita

Executive Officer, Head of Corporate Planning Department

Hiroshi Komatsu

Audit & Supervisory Board Member (Full-time)

Hiroshi Kanno

Outside Director of the Board

Rachel Soloff

Executive Director of Research

Doug Grant

General Manager, Canada

Toshiaki Uchikawa

Director, Overseas Business Planning Department

Hiroki Nakamura

Global Corporate Communications Head

Mitsuru Kameyama

Executive Officer and Chief Digital Transformation Officer (CDXO)

Mitch Katz

Senior Vice President, Global Clinical Operations

Kenji Shibata

Global Internal Audit Head

Paul Testa

Executive Vice President, Supply Chain and Operations

Toshiyuki Kurata

Managing Executive Officer and Chief Supply Chain Officer (CSCO)

Richard Wilson

Vice President, North America, Rare Disease Franchise Head

Hiroshi Sonegawa

Japan Sales & Marketing Head

Yoshihisa Suzuki

Outside Director of the Board

Takatoshi Uochi

Head of CSR Promotion

Shoko Itagaki

Managing Executive Officer and Chief People Officer (CPO)

Tomohiro Sudo

Managing Executive Officer, Chief International Business Officer

Casilda Barnes

Vice President, Head of Regulatory Affairs

Daisuke Fujiwara

Director of the Board

Takefumi Matsushita

Global Corporate Planning Head

Yoshifumi Torii

Global Research Head & Global Development Head

Jonathan Patroni

Global Quality Assurance Head

Masahiro Hara

Global Procurement Head

Ernesto Aycardi

Chief Development Officer

Nathan Hawes

Global Operational and Digital Transformation Head

Chris Valosky

Vice President, North America, CNS Franchise Head

Naohiko Kubo

Global Finance Head

Rieko Waxman

Executive Vice President, Corporate Planning

Yoko Wachi

Outside Audit & Supervisory Board Member

Motohiko Kawaguchi

Managing Executive Officer and Chief Financial Officer (CFO)

Ana Bastiani-Posner

Executive Vice President, Chief Financial Officer

Masashi Miyamoto

Representative Director, Chairman & CEO

Abdul Mullick

Representative Director, President & COO

Tara D’Orsi

Executive Vice President, Chief Compliance Officer and General Counsel

Hideaki Matsumoto

Global Product Strategy Head

Joseph Zarkoski

Vice President, North America Quality Assurance

Ian Duguid

Global Regulatory Affairs Head

Mayumi Tamura

Outside Audit & Supervisory Board Member

Hiroshi Sonekawa

Japan Sales & Marketing Head / Managing Executive Officer

Eslie Dennis

SVP, Chief Medical Officer / Global Head of Medical Affairs

Yukiko Ito

Outside Director

Masaru Otsuka

Global Information and Communication Technology Head

Patrick Adams

Vice President, North America, Market Access & Pricing

Hidekuni Kaito

Senior Vice President, North America, Head of GPM/NPP Office

Nilay Gami

VP, Global Head of PV Operations & NA Regional Head of PV

Kazuki Nemoto

Director, Legal Department

Toru Ishikura

Audit & Supervisory Board Member

Gunnar Kaufmann

Chief Scientific Officer

Takeyoshi Yamashita

Vice President and CMO

Ikuko Okubo

Global Intellectual Property Head

Takashi Oyamada

Director of the Board

Britt Byers

Senior Vice President, Human Resources North America

Simon Dawson

General Manager, Head of APAC Cluster

Kim Ga-won

HR/Office manager

Liz Butcher

Associate Director Patient Advocacy and Communications, Rare Disease

Atsushi Matsumoto

Global Supply Chain Management Head

Jeremy Morrissey

Executive Director, North America, Commercial Operations

Christina Hardy

Clinical Trial Manager

Takaaki Uochi

Global Compliance and Risk Management Head

Yasuo Fujii

Chief Strategy Officer (CSO) & Global BD Head

Sakurako Nagaoka

Global Human Resources

Eddie Garcia

Oncology Account Manager

Roshni Patel

Regulatory Affairs

Makoto Higashi

Pharmacovigilance Operations